Lung Endothelial Cells
Lung Endothelial Cells - Related Videos
06:41
Isolation of Primary Mouse Lung Endothelial Cells
0 Views •
Cited by 14 •
2021
In this article, primary lung endothelial cells were isolated and cultured from neonatal mice.
08:05
Isolation of Embryonic Ventricular Endothelial Cells
0 Views •
Cited by 4 •
2013
Primary cell culture is a useful technique for analyzing specific populations of cells, particularly from transgenic mouse embryos at specific developmental stages. Herein, embryonic ventricles are dissected and dissociated, and antibody-conjugated beads recognize and separate out the endothelial cells for further analysis.
07:36
Isolation of Mouse Coronary Endothelial Cells
0 Views •
Cited by 18 •
2016
This protocol is prepared to share our method of isolating mouse coronary endothelial cells for the purpose of imaging or to conduct molecular biological experiments.
10:13
Transplantation of Bioengineered Lung Using Decellularized Mouse Lungs and Primary Human Endothelial Cells
0 Views •
Cited by 1 •
2025
This paper describes how to create bioengineered mouse lungs using decellularization and recellularization methods. It also details subsequent orthotopic lung transplantation.
10:46
Isolation and Culture of Pulmonary Endothelial Cells from Neonatal Mice
0 Views •
Cited by 89 •
2010
Here, we describe a protocol for isolation and culture of murine pulmonary endothelial cells. This method comprises mechanic and enzymatic lung tissue dissociation as well as a 2-step purification process using anti-PECAM-1 and anti-ICAM-2 antibodies conjugated to magnetic beads, which produces a pure endothelial cell population of mostly microvascular origin.
FAQs
Cell-cell junctions act as control points for the passage of fluid, solutes, and immune cells between lung endothelial cells. Their selective behavior helps preserve the separation between circulating blood and lung tissues while allowing regulated exchange. Changes in junctional control can therefore influence vascular permeability and contribute to processes such as pulmonary edema or inflammation.
Mechanical and chemical signals guide several coordinated responses in lung endothelial cells. These signals can influence vascular tone, which affects blood vessel behavior, as well as permeability and inflammation. Studying these responses helps researchers connect environmental or biochemical changes in the pulmonary circulation with altered vascular function and disease-related injury.
Barrier regulation determines how readily fluid and immune cells move from the pulmonary blood vessels into surrounding lung tissues. If this control changes, excessive fluid movement may relate to pulmonary edema, while altered immune-cell movement may contribute to inflammation. Lung endothelial cells therefore provide a mechanistic link between vascular dysfunction and respiratory disease processes.
Research commonly examines their roles in pulmonary edema, inflammation, thrombosis, and vascular injury. These areas address different consequences of endothelial behavior, including altered permeability, immune responses, clot-related processes, and damage to pulmonary vessels. Considering these processes together helps clarify how vascular dysfunction can affect lung biology and respiratory disease mechanisms.
Lung organoids and engineered tissues provide research settings for examining lung endothelial-cell behavior in organized biological or designed tissue environments. These systems support investigation of pulmonary vascular function beyond isolated cellular behavior. Their relevance includes studying how endothelial responses relate to tissue development, vascular injury, and approaches intended to preserve or reproduce lung function.
Studies of lung endothelial cells can reveal how pulmonary vascular dysfunction relates to thrombosis and vascular injury. Because these cells respond to mechanical and chemical signals while regulating permeability and inflammation, they offer a way to connect vascular changes with broader disease mechanisms. This knowledge can support development of therapies aimed at preserving pulmonary vascular function.